These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7307008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relationship between tumor size and curability of prostatic cancer by combined chemo-hormonal therapy in rats.
    Isaacs JT.
    Cancer Res; 1989 Nov 15; 49(22):6290-4. PubMed ID: 2804976
    [Abstract] [Full Text] [Related]

  • 4. Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system.
    Isaacs JT, Wake N, Coffey DS, Sandberg AA.
    Cancer Res; 1982 Jun 15; 42(6):2353-71. PubMed ID: 7074614
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effectiveness of complete versus partial androgen withdrawal therapy for the treatment of prostatic cancer as studied in the Dunning R-3327 system of rat prostatic adenocarcinomas.
    Ellis WJ, Isaacs JT.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6041-50. PubMed ID: 4063963
    [Abstract] [Full Text] [Related]

  • 7. Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT.
    Isaacs JT, Heston WD, Weissman RM, Coffey DS.
    Cancer Res; 1978 Nov 15; 38(11 Pt 2):4353-9. PubMed ID: 698976
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A, Westin P, Bergh A, Cajander S, Damber JE.
    Cancer Res; 1994 Jul 01; 54(13):3594-601. PubMed ID: 8012987
    [Abstract] [Full Text] [Related]

  • 14. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
    Isaacs JT, Yu GW, Coffey DS.
    Invest Urol; 1981 Jul 01; 19(1):20-3. PubMed ID: 7251319
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
    Johansson A, Jones J, Pietras K, Kilter S, Skytt A, Rudolfsson SH, Bergh A.
    Prostate; 2007 Nov 01; 67(15):1664-76. PubMed ID: 17854058
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB, Nelson JB, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.